Management of red blood cell alloimmunization in pregnancy

Branger, 2006, Epidemiology of anti-D alloimmunization during pregnancy, J Gynecol Obstet Biol Reprod, 35 Moise, 2012, Management and prevention of red cell alloimmunization in pregnancy: a systematic review, Obstet Gynecol, 120, 1132, 10.1097/AOG.0b013e31826d7dc1 Poissonnier M-H, Maynier M, Lachaux V de, Chavinié J, Soulié J-C, Brossard Y, et al. Incompatibilité fœtomaternelle érythrocytaire; 1998. http://www.em-premium.com.doc-distant.univ-lille2.fr/article/1562/resultatrecherche/2. [cited 2015 Aug 6]. Cortey, 2012, Incompatibilités fœtomaternelles érythrocytaires, EMC Pediatrie, 7, 1 Gariod, 2004, Kell alloimmunization in pregnancy, J Gynecol Obstet Biol Reprod, 33, 637, 10.1016/S0368-2315(04)96605-7 Lo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet Lond Engl, 350, 485, 10.1016/S0140-6736(97)02174-0 Rouillac-Le Sciellour, 2004, Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women, Mol Diagn J Devoted Underst Hum Dis Clin Appl Mol Biol, 8, 23 Vivanti, 2016, Am J Obstet Gynecol, 215 Mailloux, 2013, Apport du génotypage fœtal non invasif sur sang maternel pour la prise en charge des allo-immunisations antiérythrocytaires et la prévention Rhésus, Rev Med Perinat, 5, 203, 10.1007/s12611-013-0259-z Geifman-Holtzman, 2009, Noninvasive fetal RhCE genotyping from maternal blood, BJOG Int J Obstet Gynaecol, 116, 144, 10.1111/j.1471-0528.2008.01744.x Carbonne, 2010, Follow-up of pregnancies with red cell alloimmunisation: state-of-the art, Gynecol Obstet Fertil, 38, 205, 10.1016/j.gyobfe.2010.01.012 Mari, 2000, Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses, N Engl J Med, 342, 9, 10.1056/NEJM200001063420102 Bhide, 2013, ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics, Ultrasound Obstet Gynecol, 41, 233, 10.1002/uog.12371 Ruma, 2009, Angle correction can be used to measure peak systolic velocity in the fetal middle cerebral artery, Am J Obstet Gynecol, 200, 397, 10.1016/j.ajog.2008.11.002 Sallout, 2004, The effect of fetal behavioral states on middle cerebral artery peak systolic velocity, Am J Obstet Gynecol, 191, 1283, 10.1016/j.ajog.2004.03.018 Swartz, 2009, The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery, Obstet Gynecol, 113, 1225, 10.1097/AOG.0b013e3181a4b4b5 Zimmermann, 2002, Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat, BJOG Int J Obstet Gynaecol, 109, 746, 10.1111/j.1471-0528.2002.01314.x Liley, 1961, Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization, Am J Obstet Gynecol, 82, 1359, 10.1016/S0002-9378(16)36265-2 Oepkes, 2006, Doppler ultrasonography versus amniocentesis to predict fetal anemia, N Engl J Med, 355, 156, 10.1056/NEJMoa052855 Garabedian, 2015, Management of severe fetal anemia by Doppler measurement of middle cerebral artery: are there other benefits than reducing invasive procedures?, Eur J Obstet Gynecol Reprod Biol, 192, 27, 10.1016/j.ejogrb.2015.06.016 Liley, 1963, Intrauterine transfusion of foetus in haemolytic disease, Br Med J, 2, 1107, 10.1136/bmj.2.5365.1107 Canlorbe, 2011, Management of very early fetal anemia resulting from red cell alloimmunization before 20 weeks of gestation, Obstet Gynecol, 118, 1323, 10.1097/AOG.0b013e318235e3bb Rodeck, 1984, The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions, Am J Obstet Gynecol, 150, 769, 10.1016/0002-9378(84)90683-5 Giannina, 1998, A simple method to estimate volume for fetal intravascular transfusions, Fetal Diagn Ther, 13, 94, 10.1159/000020813 Brennand, 2008, Fetal anaemia: diagnosis and management, Best Pract Res Clin Obstet Gynaecol, 22, 15, 10.1016/j.bpobgyn.2007.08.005 Papantoniou, 2013, Therapeutic management of fetal anemia: review of standard practice and alternative treatment options, J Perinat Med, 41, 71, 10.1515/jpm-2012-0093 Grannum, 1986, In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis, N Engl J Med, 314, 1431, 10.1056/NEJM198605293142207 Poissonnier, 1989, Two hundred intrauterine exchange transfusions in severe blood incompatibilities, Am J Obstet Gynecol, 161, 709, 10.1016/0002-9378(89)90386-4 Garabedian, 2014, Is intrauterine exchange transfusion a safe procedure for management of fetal anaemia?, Eur J Obstet Gynecol Reprod Biol, 179, 83, 10.1016/j.ejogrb.2014.05.008 Guilbaud, 2016, In utero treatment of severe fetal anemia resulting from fetomaternal red blood cell incompatibility: a comparison of simple transfusion and exchange transfusion, Eur J Obstet Gynecol Reprod Biol, 201, 85, 10.1016/j.ejogrb.2016.03.037 Mari, 2005, Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions, Am J Obstet Gynecol, 193, 1117, 10.1016/j.ajog.2005.06.078 Detti, 2001, Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization, Am J Obstet Gynecol, 185, 1048, 10.1067/mob.2001.118161 Friszer, 2014, Determination of the optimal timing of serial in utero transfusions in red blood cell alloimmuniation, Ultrasound Obstet Gynecol, 46, 600, 10.1002/uog.14772 Scheier, 2006, Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions, Am J Obstet Gynecol, 195, 1550, 10.1016/j.ajog.2006.03.060 Ghesquière, 2017, Should optimal timing between two intrauterine transfusions be based on estimated daily decrease of hemoglobin or on measurement of fetal middle cerebral artery peak systolic velocity?, Transfusion, 57, 889, 10.1111/trf.13980 Mari, 2015, Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline: the fetus at risk for anemia – diagnosis and management, Am J Obstet Gynecol, 212, 697, 10.1016/j.ajog.2015.01.059 Klumper, 2000, Benefits and risks of fetal red cell transfusion after 32 weeks gestation, Eur J Obstet Gynecol Reprod Biol, 92, 91, 10.1016/S0301-2115(00)00430-9 Van Kamp, 2005, Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red cell alloimmunization, Am J Obstet Gynecol, 192, 171, 10.1016/j.ajog.2004.06.063 Lindenburg, 2013, Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation, BJOG Int J Obstet Gynaecol, 120, 847, 10.1111/1471-0528.12063 Zwiers, 2017, Complications of intrauterine intravascular blood transfusions: lessons learned after 1678 procedures, Ultrasound Obstet Gynecol, 50, 180, 10.1002/uog.17319 Zwiers, 2017, Intrauterine transfusion and noninvasive treatment options for hemolytic disease of the fetus and newborn – review on current management and outcome, Expert Rev Hematol, 10, 337, 10.1080/17474086.2017.1305265 Alonso, 1994, Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease, J Perinat Med, 22, 415, 10.1515/jpme.1994.22.5.415 Berlin, 1985, Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin, Lancet Lond Engl, 1, 1153, 10.1016/S0140-6736(85)92451-1 Branch, 2001, Obstetric uses of intravenous immunoglobulin: successes, failures, and promises, J Allergy Clin Immunol, 108, S133, 10.1067/mai.2001.117821 Sacher, 1989, Intravenous gamma globulin in pregnancy: a review, Obstet Gynecol Surv, 44, 25, 10.1097/00006254-198901000-00003 Gottvall, 1995, Alloimmunization during pregnancy treated with high-dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus, Acta Obstet Gynecol Scand, 74, 777, 10.3109/00016349509021196 Voto, 1997, High-dose gamma globulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease, J Perinat Med, 25, 85, 10.1515/jpme.1997.25.1.85 De la Cámara, 1988, High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization, N Engl J Med, 318, 519, 10.1056/NEJM198802253180816 Margulies, 1991, High-dose intravenous IgG for the treatment of severe rhesus alloimmunization, Vox Sang, 61, 181, 10.1111/j.1423-0410.1991.tb00944.x Chitkara, 1990, High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?, Obstet Gynecol, 76, 703 Deka, 2013, Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study, Fetal Diagn Ther, 34, 146, 10.1159/000353236 Ulm, 1999, Immunoglobulin administration to fetuses with anemia due to alloimmunization to D, Transfusion, 39, 1235, 10.1046/j.1537-2995.1999.39111235.x Kriplani, 2007, Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease, Gynecol Obstet Invest, 63, 176, 10.1159/000097661 Porter, 1997, Intravenous immune globulin in the management of severe Rh D hemolytic disease, Obstet Gynecol Surv, 52, 193, 10.1097/00006254-199703000-00022 Thung, 2005, The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia, Am J Obstet Gynecol, 193, 1094, 10.1016/j.ajog.2005.05.048 Schwartz, 2016, Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue, J Clin Apheresis, 31, 149 Bowman, 1991, Antenatal suppression of Rh alloimmunization, Clin Obstet Gynecol, 34, 296, 10.1097/00003081-199106000-00010 Caudle, 1982, The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization, Clin Obstet Gynecol, 25, 313, 10.1097/00003081-198206000-00011 Barclay, 1980, Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors, Br Med J, 280, 1569, 10.1136/bmj.280.6231.1569 Marson, 2015, Therapeutic apheresis in pregnancy: general considerations and current practice, Transfus Apher Sci, 53, 256, 10.1016/j.transci.2015.11.004 Nwogu, 2017, Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion, Transfusion Bellone, 2014, Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion, Transfusion, 54, 2118, 10.1111/trf.12633 Isojima, 2011, Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy, J Clin Apheresis, 26, 216, 10.1002/jca.20288 Trevett, 2005, Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn, Am J Obstet Gynecol, 192, 478, 10.1016/j.ajog.2004.08.016 Thomas, 2007, Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization, Cochrane Database Syst Rev, CD005541 McDonald, 2008, Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD004074.pub2 Menget, 2013, Intérêt du clampage retardé du cordon ombilical chez le nouveau-né, Arch Pediatr, 20, 1022, 10.1016/j.arcped.2013.06.016 Mercer, 2006, Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial, Pediatrics, 117, 1235, 10.1542/peds.2005-1706 McAdams, 2014, Time to implement delayed cord clamping, Obstet Gynecol, 123, 549, 10.1097/AOG.0000000000000122 Garabedian, 2016, Benefits of delayed cord clamping in red blood cell alloimmunization, Pediatrics, 137, e20153236, 10.1542/peds.2015-3236 Van Kamp, 2001, The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment, Am J Obstet Gynecol, 185, 668, 10.1067/mob.2001.116690 Van Kamp, 2004, Treatment of fetal anemia due to red cell alloimmunization with intrauterine transfusions in the Netherlands, 1988–1999, Acta Obstet Gynecol Scand, 83, 731, 10.1111/j.0001-6349.2004.00394.x Van Klink, 2011, Long-term neurodevelopmental outcome after intrauterine transfusion for fetal anemia, Early Hum Dev, 87, 589, 10.1016/j.earlhumdev.2011.07.003 Leijser, 2012, Brain ultrasound findings in neonates treated with intrauterine transfusion for fetal anaemia, Early Hum Dev, 88, 717, 10.1016/j.earlhumdev.2012.02.013 Lindenburg, 2012, Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study, Am J Obstet Gynecol, 206 Anthonioz, 2006, MRI aspects of anoxic-ischemic encephalopathy of the term and premature newborn, J Radiol, 87, 1651, 10.1016/S0221-0363(06)74144-0 Carbonne, 2008, Prenatal diagnosis of anoxic cerebral lesions caused by profound fetal anemia secondary to maternal red blood cell alloimmunization, Obstet Gynecol, 112, 442, 10.1097/AOG.0b013e3181656a11 Ghi, 2004, Sonographic demonstration of brain injury in fetuses with severe red blood cell alloimmunization undergoing intrauterine transfusions, Ultrasound Obstet Gynecol, 23, 428, 10.1002/uog.1035